WBA - Opioid Crisis and Corporate Accountability: Purdue's Settlement in the Spotlight | Benzinga
The U.S. Supreme Court is reviewing a contentious bankruptcy settlement involving Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family.
In 2019, Purdue Pharma filed for Chapter 11 bankruptcy as a response to the numerous lawsuits claiming that its opioid product, OxyContin, played a pivotal role in the opioid crisis, which led to over half a million overdose deaths in the U.S. in two decades.
This settlement, if upheld, could grant the Sacklers legal immunity from future lawsuits in exchange for a substantial financial contribution to resolve existing claims, Reuters noted.
This ...